Share this Job

New Product Planning Lead- CNS

Date: Aug 16, 2019

Location: Philadelphia, PA, US

Company: Spark Therapeutics


Join the Spark Team


We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our shared mission is to challenge the inevitability of genetic disease by discovering, developing, and delivering treatments in ways unimaginable – until now.


We don’t follow footsteps. We create the path.




The New Product Planning Lead will be responsible for bringing customer insights and market knowledge to shape the profile for commercial success and inform decision making for Spark's CNS programs.


The individual will also lead cross-functional strategic portfolio initiatives and perform commercial assessments for external Business Development opportunities.


The New Product Planning Lead will be a core member of the CNS Candidate Development Team and partner closely with the Candidate Development Team leader, as well as colleagues from Market Access, Patient Advocacy, Clinical Development, CMC, Medical, Commercial Development, Corporate Planning & Analytics and Business Development functions.

  • Provide strategic commercial input into CNS pipeline programs
  • Lead the development and validation of target product profiles, prepare market assessments and drive patient journey work
  • Lead research with physicians (with Clinical Development), payers (with Market Access) and patients (with Patient Advocacy Group) to address other questions impacting the program and key decisions
  • Liaise with Corporate Planning & Analytics on commercial forecast assumptions and sensitivity analyses for internal and external programs
  • Partner with Global Market Access Drive on payer projects and value story
  • Develop business case for life-cycle management opportunities
  • Develop strategic imperatives and functional objectives with the Team
  • Provide New Product Planning deliverables for program stage gates
  • Develop initial product positioning and differentiation
  • Transition responsibilities to Commercial after phase III initiation
  • Participate in or lead portfolio strategic initiatives, in partnership with R&D, to identify and prioritize new opportunities and present recommendations to leadership
  • Take the lead on congress activities for early pipeline assets
  • Work with Corporate Communications, Medical, Patient Advocacy and R&D on disease area and pipeline asset communication strategy and plan
  • Liaise with business development to provide due diligence support in creating commercial market assessments and championing external opportunities relative to internal portfolio
  • Liaise with external experts to assess new business opportunities
  • Collaborate with external partners
  • BS/BA required; Advanced degree preferred
  • Minimum 10+ years life science industry experience required; with at least 6+ years of experience in global commercial or in-line marketing and sales
  • Experience in CNS and Specialty disease areas required
  • Launch experience strongly preferred
  • Demonstrated experience in leading customer insight and cross-functional strategic projects
  • Gene therapy and/or rare disease experience an advantage
  • Market access and payer experience an advantage
  • Strong marketing and business experience
  • Analytical and strategic thinker
  • Strong communicator with ability to influence key strategic discussions
  • Proven ability to lead multiple cross-functional projects efficiently and independently
  • Understanding of drug development process
  • Demonstrated ability to successfully collaborate with R&D organization
  • Understanding of both US and European marketing and payer environments an advantage
  • Authority to decide on vendor and implement customer insight, competitive intelligence and strategic projects within agreed upon budget
  • Authority to represent New Product Planning in all Asset Team and Candidate Development Team discussions and decisions. Ownership for TPP, commercial strategy and business case

  • Decisions to be referred are those that represent major changes in strategy, risk, timelines or budget

Nearest Major Market: Philadelphia